| Trial ID: | L1982 |
| Source ID: | NCT02161276
|
| Associated Drug: |
Tntl Capsule
|
| Title: |
Clinical Trials for the Optimal Dosage of Tang Ning Tongluo Capsule
|
| Acronym: |
TNTL
|
| Status: |
COMPLETED
|
| Study Results: |
NO
|
| Results: |
|
| Conditions: |
Accidental Exposure While Preparing Drug for Administration
|
| Interventions: |
DRUG: TNTL capsule|DRUG: Placebo
|
| Outcome Measures: |
Primary: The decline glycosylated hemoglobin A1C and blood glucose level, Decline in Hemoglobin A1C and blood glucose level, up to 8 weeks | Secondary: The clinical composite safety evaluation of Tangning Tongluo Capsule in the treatment of type II diabetes participants, Routine check for blood, urine, stool + occult blood, liver function (ALT, AST, AKP, GGT, TBIL), renal function (BuN, Cr), ECG before treatment with 1 times per week., 2 months
|
| Sponsor/Collaborators: |
Sponsor: Guizhou Bailing Group Pharmaceutical Co Ltd | Collaborators: China-Japan Friendship Hospital
|
| Gender: |
ALL
|
| Age: |
ADULT, OLDER_ADULT
|
| Phases: |
PHASE1|PHASE2
|
| Enrollment: |
110
|
| Study Type: |
INTERVENTIONAL
|
| Study Designs: |
Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: DOUBLE (PARTICIPANT, INVESTIGATOR)|Primary Purpose: TREATMENT
|
| Start Date: |
2014-04
|
| Completion Date: |
2014-09
|
| Results First Posted: |
|
| Last Update Posted: |
2014-09-11
|
| Locations: |
Tianyuan Hospital of Guiyang City, Guiyang, Guizhou, 550007, China
|
| URL: |
https://clinicaltrials.gov/show/NCT02161276
|
